Table 1.
ERAP, HLA-C, KIR Combination | Associated Combination | Compared Groups |
p | pcorr. | OR | 95% CI | Effect | Table |
---|---|---|---|---|---|---|---|---|
Female ERAP/male HLA-C | ||||||||
ERAP1 rs30187 C>T/HLA-C | TT/C1C2 | IVF vs. Fertile | 0.006 | 0.050 | 2.843 | 1.30–6.92 | ↑ | Supplementary Table S2 |
ERAP1 rs27044 C>G/HLA-C | CC/C1C1 | RIF vs. SIVF | 0.005 | 0.044 | 0.343 | 0.15–0.75 | ↓ | Supplementary Table S2 |
ERAP1 rs27044 C>G/HLA-C | CC/C1C2 | SIVF vs. Fertile | 0.003 | 0.027 | 0.442 | 0.25–0.78 | ↓ | Supplementary Table S2 |
Female ERAP/male HLA-C/female KIR | ||||||||
ERAP1 rs27044 C>G/HLA-C/KIR | CC/C1C2/Bx | RIF vs. Fertile | 0.004 | 0.037 | 0.428 | 0.23–0.78 | ↓ | Supplementary Table S3 |
ERAP1 rs27044 C>G/HLA-C/KIR | CG/C1C2/Bx | RIF vs. Fertile | 0.006 | 0.050 | 2.313 | 1.25–4.33 | ↑ | Supplementary Table S3 |
Male ERAP/female HLA-C/female KIR | ||||||||
ERAP1 rs30187 C>T/HLA-C/KIR | CT/C2C2/AA | RIF vs. SIVF | 0.005 | 0.049 | 24.000 | 1.76–1549.16 | ↑ | Supplementary Table S4 |
Male ERAP/male HLA-C/female KIR | ||||||||
ERAP1 rs27044 C>G/HLA-C/KIR | GG/C1+/AA | RIF vs. SIVF | 0.005 | 0.031 | 0.114 | 0.01–0.66 | ↓ | Supplementary Table S5 |
ERAP1 rs27044 C>G/HLA-C/KIR | CG/C2C2/Bx | RIF vs. SIVF | 0.004 | 0.033 | 0.096 | 0.01–0.56 | ↓ | Supplementary Table S5 |
↑—susceptibility; ↓—protection; IVF-ET—in vitro fertilization embryo transfer; RIF—recurrent implantation failure; SIVF—successful pregnancy after IVF-ET; p—probability; pcorr.—probability after Bonferroni correction; OR—odds ratio; 95% CI—confidence interval from two-sided Fisher’s exact test.